Castle Biosciences Inc (CSTL) Company Profile & Statistics

Castle Biosciences Inc
CSTL
(Nasdaq - US)
Open
29.92
+1.04 (+3.60%)
in:usd•As of: Nov 22, 2024 11:33 UTC -5
Open
29.02
High
29.98
Low
28.88

About Castle Biosciences Inc

CEO

Derek J. Maetzold

Headquarters

505 s. friendswood drive, suite 401

friendswood, tx 77546, united states

Auditor

KPMG LLP

Employees

610

Share Holders

132

Website

https://castlebiosciences.com

Industry

medical specialties

Sector

health technology

Company Overview

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Castle Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	838.06M
Enterprise Value	753.12M
Enterprise Value/EBITDA (ttm)	132.06
Price to Earnings Ratio (ttm)	144.35
Price to Book (mrq)	1.83
Price to Sales (ttm)	2.59
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	81.82%
Operating Margin (ttm)	1.95%
Profit Margin (ttm)	1.38%
Return on Equity (ttm)	1.47%
Return on Invested Capital (ttm)	1.29%
Return on Assets (ttm)	1.27%

Income Statement

Revenue (ttm)	311.88M
Revenue Per Share (ttm)	11.14
Gross Profit (ttm)	255.43M
EBITDA (ttm)³	5.70M
Net Income Avi to Common (ttm)	6.08M
Diluted EPS (ttm)	0.20

Share Statistics

Beta (5Y Monthly)	0.99
52-Week Change	49.15%
S&P500 52-Week Change	30.72%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	28.01M
Dividend Yield	0.00%
Float ⁴	25.99M
% Held by Insiders	7.20%
% Held by Institutions	92.60%

Balance Sheet

Total Cash (mrq)	279.79M
Total Cash Per Share (mrq)	9.99
Total Debt (mrq)	10.02M
Total Debt/Equity (mrq)	2.27%
Current Ratio (mrq)	7.78%
Quick Ratio (mrq)	7.64%
Book Value Per Share (mrq)	15.77

Cash Flow

Operating Cash Flow Per Share (ytd)	1.38
Free Cash Flow (ytd)	19.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Castle Biosciences Inc

Trade With A Regulated Broker